We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Diagnosing Liver Cancer Using Genetically Modified Probiotic Bacteria

By LabMedica International staff writers
Posted on 07 Jun 2015
Print article
Image: A space-filling model of firefly luciferin. Color coding: yellow = sulfur; blue = nitrogen; black = carbon; red = oxygen; white = hydrogen (Photo courtesy of Wikimedia Commons).
Image: A space-filling model of firefly luciferin. Color coding: yellow = sulfur; blue = nitrogen; black = carbon; red = oxygen; white = hydrogen (Photo courtesy of Wikimedia Commons).
A genetically engineered variety of the probiotic bacterium Escherichia coli Nissle 1917 was used to generate a luminescent diagnostic biomarker that could be detected in the urine of rodents with liver tumors.

Investigators at the Massachusetts Institute of Technology (Cambridge, MA, USA) and the University of California, San Diego (USA) genetically engineered E. coli Nissle 1917 to carry the gene that encodes a lacZ reporter enzyme, which would normally cleave lactose into glucose and galactose. For the current study galactose linked-luciferin was provided as the substrate in test rodents, and the enzyme acted on this complex to produce free, luminescent luciferin, which was excreted and could be detected in the urine.

The investigators reported in the May 27, 2015, online edition of the journal Science Translational Medicine that E. coli Nissle 1917 robustly colonized tumor tissue in rodent models of liver metastasis after oral delivery but did not colonize healthy organs or fibrotic liver tissue. The microbial diagnostic generated a high-contrast urine signal through selective expansion in liver metastases (106-fold enrichment) and high expression of the lacZ reporter maintained by engineering a stable plasmid system. No deleterious health effects were detected in the mice more than 12 months after oral delivery.

The orally delivered bacteria did not accumulate in tumors all over the body, but did become established in nearly 90% of metastatic tumors in mice with colon cancer that had spread to the liver.

"We realized that if we gave a probiotic, we were not going to be able to get bacteria concentrations high enough to colonize the tumors all over the body, but we hypothesized that if we had tumors in the liver they would get the highest dose from an oral delivery," said senior author Dr. Sangeeta Bhatia, professor of health sciences, electrical engineering, and computer science, at the Massachusetts Institute of Technology. "There are interventions, like local surgery or local ablation, that physicians can perform if the spread of disease in the liver is confined, and because the liver can regenerate, these interventions are tolerated. New data are showing that those patients have a higher survival rate, so there is a particular need for detecting early metastasis in the liver."

Related Links:

Massachusetts Institute of Technology
University of California, San Diego


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Monkeypox Test
Monkeypox Virus Rapid Antibody Test
New
ELISA System
ABSOL HS DUO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.